Here's Why We're Watching Lexaria Bioscience's (NASDAQ:LEXX) Cash Burn Situation [Yahoo! Finance]
Lexaria Bioscience Corp. (LEXX)
Company Research
Source: Yahoo! Finance
done very well over the last year, with the share price soaring by 352%. But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse. In light of its strong share price run, we think now is a good time to investigate how risky Lexaria Bioscience's cash burn is. For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. The first step is to compare its cash burn with its cash reserves, to give us its 'cash runway'. See our latest analysis for Lexaria Bioscience Does Lexaria Bioscience Have A Long Cash Runway? A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. When Lexaria Bioscience last reported its February 2024 balance sheet in April 2024, it had zero debt and cash worth US$4.8m. In the last year, its cash bur
Show less
Read more
Impact Snapshot
Event Time:
LEXX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEXX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEXX alerts
High impacting Lexaria Bioscience Corp. news events
Weekly update
A roundup of the hottest topics
LEXX
News
- Lexaria Receives Two New Medical-Treatment Patents in Hypertension and Epilepsy [Yahoo! Finance]Yahoo! Finance
- Lexaria Receives Two New Medical-Treatment Patents in Hypertension and EpilepsyAccesswire
- Dosing Begins in Lexaria's Comprehensive GLP-1 Animal Study [Yahoo! Finance]Yahoo! Finance
- Dosing Begins in Lexaria's Comprehensive GLP-1 Animal StudyAccesswire
- Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study [Yahoo! Finance]Yahoo! Finance
LEXX
Analyst Actions
- 3/5/24 - Maxim Group
LEXX
Sec Filings
- 5/15/24 - Form 4
- 5/10/24 - Form 4
- 5/10/24 - Form 4
- LEXX's page on the SEC website